• / Free eNewsletters & Magazine
  • / My Account
Home>Funds>FaithShares Methodist Values

FaithShares Methodist Values

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. Aurinia Pharmaceuticals Announces Voclosporin Meets Primary Endpoint in Phase IIB AURA-LV Study in Lupus Nephritis

    Aurinia Pharmaceuticals Announces Voclosporin Meets Primary Endpoint in Phase IIB AURA-LV Study in Lupus Nephritis

12
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.